The government said Tuesday it will start reviewing drug prices every year, instead of every two years, in a bid to reduce mounting health care costs — a move that reflects growing resistance to rising drug prices around the world.
The government will also review all drug prescription prices instead of limiting its list to pharmaceuticals judged to be far more expensive than their overseas counterparts. The current system has been criticized as keeping drug prices unnecessarily high in Japan.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.